Clinical Trial Update: SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating SNMC (Stronger Neo-Minophagen C) for acute hepatitis after transarterial chemoembolization in hepatocellular carcinoma patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• SNMC

Snippet

Sponsor: Chimei Medical Center | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: COMPLETED